Related Experiment Videos
A role for anaphylactic sensitization in tumor control.
International Archives of Allergy and Applied Immunology
|January 1, 1985
Summary
Anaphylaxis, an allergic immune response, may prevent tumor development. Mice with high IgE antibody levels showed reduced tumor incidence and slower growth, suggesting a protective role for IgE in cancer prevention.
Area of Science:
- Immunology
- Oncology
- Allergy Research
Background:
- Tumor development is a complex process influenced by the immune system.
- The role of specific immune responses, such as IgE-mediated reactions, in cancer prevention is not fully understood.
Purpose of the Study:
- To investigate the potential preventive effect of an anaphylactic condition on chemically induced fibrosarcoma development.
- To determine if pre-existing IgE responses influence tumor incidence, growth rate, and survival.
Main Methods:
- C57BL/6J mice were immunized or hyperimmunized with egg albumin in alum to elicit specific IgE responses.
- Fibrosarcoma was chemically induced after the immunization protocols.
- Tumor incidence, growth rate, and animal survival were monitored and compared between groups.
Main Results:
- Mice with optimal IgE responses (titers > 640) exhibited a significant reduction in tumor incidence.
- These mice also showed increased survival time and a decreased tumor growth rate.
- Hyperimmunized mice with suppressed IgE responses did not differ from controls in tumor incidence or survival.
Conclusions:
- The ability to mount an IgE response to unrelated antigens may suppress tumor development.
- These findings suggest a potential preventive role for IgE-mediated immunity in cancer.
- Further research into IgE's role in tumor suppression is warranted.